Maxcyte (MXCT) Debt Ratio (2020)

Maxcyte's (MXCT) quarterly Debt Ratio came in at 0.09 in Q4 2020.

Maxcyte (MXCT) Debt Ratio (2020) Analysis & Trends

Maxcyte (MXCT) has 1 years of Debt Ratio data on file, last reported at 0.09 in Q4 2020.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.09 in Q4 2020; TTM through Dec 2020 was 0.09, a N/A change from a year earlier, with the FY2020 full-year figure at 0.09, changed N/A from the prior year.
Debt Ratio for Q4 2020 stood at 0.09.
Over the last five years, Debt Ratio for MXCT reached as high as 0.09 in Q4 2020 and fell as low as 0.09 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	0.31
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	0.32
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	0.30
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	0.04
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	0.27
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	0.30
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	0.30
10	Maxcyte	110.62 Mn	110.62 Mn	8.08 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	0.09